Showing results (241-250 of 261) with videos related to
Sort By:
Pageof 27
Blood|October 3, 2013
Robust ZFN-mediated genome editing in adult hemophilic miceXavier M Anguela, Rajiv Sharma, Yannick Doyon, et al.European Journal of Heart Failure|February 10, 2021
Dynamic changes in cardiovascular and systemic parameters prior to sudden cardiac death in heart failure with reduced ejection fraction: a PARADIGM-HF analysisLuis E Rohde, Muthiah Vaduganathan, Brian L Claggett, et al.ESC Heart Failure|August 24, 2017
Heart failure: preventing disease and death worldwidePiotr Ponikowski, Stefan D Anker, Khalid F AlHabib, et al.Arquivos Brasileiros De Cardiologia|January 29, 2025
The Southern Brazilian Registry of Atrial Fibrillation (SBR-AF Registry): Predictors of Atrial Arrhythmia Recurrence after First-Time Catheter AblationCaique M P Ternes, Luis E Rohde, Alexander Dal Forno, et al.Heart (British Cardiac Society)|December 28, 2020
Revisiting heart failure assessment based on objective measures in NYHA functional classes I and IIMariana Blacher, André Zimerman, Pedro H B Engster, et al.Academic Pathology|November 19, 2024
Social media in pathology and laboratory medicine: A systematic reviewAllyson Flippo, Bhakti Dixit, Casey P Schukow, et al.American Heart Journal|December 11, 2017
Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trialPriscila Raupp da Rosa, Luis E Rohde, Madeni Doebber, et al.European Journal of Heart Failure|December 30, 2021
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HFJames P Curtain, Alice M Jackson, Li Shen, et al.Circulation. Heart Failure|March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF AnalysisLuis E Rohde, Brian L Claggett, Emil Wolsk, et al.European Journal of Cancer Care|August 5, 2017
The international phase 4 validation study of the EORTC QLQ-SWB32: A stand-alone measure of spiritual well-being for people receiving palliative care for cancerB Vivat, T E Young, J Winstanley, et al.Pageof 27